RE:RE:RE:RE:RE:RE:RE:Haha.. Now we know...All of the prescription products listed are on Vanc's list. The question is: how many other companies list these pharmaceuticals in their profiles?
MAZZMEX wrote: Heres the news release from Cip.h...Canadian Int'l Pharma products approved for sale 2017-11-20 12:53 ET - News Release Mr. Mehrun Payravi reports CANADIAN INTERNATIONAL PHARMA CORP. PROCEEDS WITH AGREEMENT TO SELL GENERIC AND OTC PRODUCTS IN CANADA In 2016, Canadian International Pharma Corp. entered into an agency agreement with a Canadian-based pharmaceutical company that discovers, develops, manufactures and markets a broad range of health care products, to sell and market a number of generic and over-the-counter medications in Canada, and in connection therewith, the manufacturer has recently obtained required approvals for selling certain of its products in Canada. The agreement permits Canadian International to generate sales of the products in the provinces of British Columbia, Alberta and Saskatchewan, with additional territories under review. Initially, Canadian International will be marketing a variety of the products, including such generic medications as Anastrozole (breast cancer treatment), Citalopram (depression), Letrozole (breast cancer), Ondansetron (nausea from cancer treatment), Rizatriptan Odt (migraine) and Zolmitriptan (migraine), as well as certain over-the-counter products, such as Bisacodyl (laxative), Comfilax (herbal product for digestion and constipation) and Hot Lemon Relief (cold and flu relief). Additionally, the company has the potential opportunity of marketing other products as the manufacturer receives DIN (drug identification number) registrations for such medications. In light of the above developments, the company will be actively presenting the products to a number of chain and independent pharmacies located in British Columbia, Alberta and Saskatchewan in an effort to obtain 2018 product placements and listings for such products. About Canadian International Pharma Corp. Canadian International Pharma is an emerging multifaceted pharmaceutical company that is in the process of developing generic and nutraceutical drug manufacturing, distribution and sales. In 2016, Canadian International Pharma launched its PharmaCert program. PharmaCert is a certification program for testing and measuring finished dosage forms of nutraceutical and pharmaceutical medications. The company has also aligned itself with Canadian and U.S. manufacturers with the objective of manufacturing generics and nutraceuticals for Canadian and overseas markets. We seek Safe Harbor. 2017 Canjex Publishing Ltd. All rights reserved. quote=forzacalabria]Is there a connection between cip.h and vanc ??? What could it be potentially?? >
[/quote]